- Filed
- May 2, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 25, 2025 | 104.71M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $1.44B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $1.44B |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.05B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $920.3M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.1B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.4B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $4.22B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $3.51B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $3.36B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.48B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $8.67B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $7.79B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 106.1M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $76.6M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $58.5M |
| Capex | Q1 2025 · Mar 31, 2024 | $7.3M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $895.6M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $4.02B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $3.99B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $1.96 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.97 |
| Net Income | Q1 2025 · Mar 31, 2024 | $209.5M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $282.4M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $502.1M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $455.1M |